51 – 60 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
(
- Contribution to journal › Article
-
Mark
Effects of cyclin D-1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
(
- Contribution to journal › Article
-
Mark
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2011
-
Mark
Exploring the link between MORF4L1 and risk of breast cancer
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
(
- Contribution to journal › Article
-
Mark
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
(
- Contribution to journal › Article
-
Mark
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
(
- Contribution to journal › Article
-
Mark
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
(
- Contribution to journal › Article
-
Mark
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
(
- Contribution to journal › Article
- 2010
-
Mark
Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
(
- Contribution to journal › Article